ArticleNeurotherapeutics : the journal of the American Society for Experimental NeuroTherapeutics2026
Commentary: Lysosomal enzymes engineered to cross the blood-brain barrier are reshaping the therapeutic landscape of neuronopathic mucopolysaccharidoses.
Nicolina Cristina Sorrentino et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.